Antipsychotic Augmentation vs Monotherapy in Schizophrenia

To augment or not to augment? That is the question.

View the slides in PDF format. Also see: Antipsychotics and Breast Cancer Risk.

Related Videos
Related Content

Gut Microbiota and SSRIs in Major Depression

March 29th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023

Gut Microbiota and SSRIs in Major Depression

March 29th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023

Gut Microbiota and SSRIs in Major Depression

March 29th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Is Clozapine-Induced Weight Gain Dose-Dependent?

March 27th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.